Shopping Cart
Remove All
Your shopping cart is currently empty
PPAR agonist4 (Compound 12) is an orally active PPAR agonist that activates PPARα, PPARδ, and PPARγ with EC50 values of 0.7 μM, 0.7 μM, and 1.8 μM, respectively. It also exhibits anti-hepatic fibrosis activity.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | PPAR agonist4 (Compound 12) is an orally active PPAR agonist that activates PPARα, PPARδ, and PPARγ with EC50 values of 0.7 μM, 0.7 μM, and 1.8 μM, respectively. It also exhibits anti-hepatic fibrosis activity. |
| Targets&IC50 | PPARγ:1.8 μM (EC50), PPARα:0.7 μM (EC50), PPARδ:0.7 μM (EC50) |
| In vitro | PPAR agonist 4 (3-10 μM) dose-dependently enhances the expression of PPARα/δ target genes CPT1A, PDK4, and ANGPTL4 in HepG2 cells, as well as PPARγ target genes CD36 and FABP4 in HEK293 cells. |
| In vivo | PPAR agonist 4 (3-30 mg/kg, oral, 3 weeks) effectively reduces collagen deposition and inhibits inflammatory cell infiltration in a mouse model of liver fibrosis induced by CCl4. |
| Formula | C23H28F3N3O3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.